Associations of two SNPs (rs3077, rs9277535) with chronic HBV infection and HBsAg seroclearance.

<p>Associations of two SNPs (rs3077, rs9277535) with chronic HBV infection and HBsAg seroclearance.</p

Baseline patient characteristics.

Baseline patient characteristics.</p

SVR₁₂ according to baseline patient characteristics and on-treatment HCV viral decline.

SVR12 according to baseline patient characteristics and on-treatment HCV viral decline.</p

Comparison of association between each haplotype of rs3077-rs9277535 and HBsAg seroclearance.

<p>Comparison of association between each haplotype of rs3077-rs9277535 and HBsAg seroclearance.</p

Long-term events of groups according to their hepatitis activities.

<p>Data are expressed as median (25th, 75th quartile) or number (percentage) as indicated.</p>†<p>P<.001,</p>*<p>P<.05 compared with its baseline level.</p>‡<p>P for trend.</p

Baseline characteristics of study cohorts.

<p>Baseline characteristics of study cohorts.</p

Characteristics of HBeAg-negative HBsAg carriers according to their hepatitis activities.

<p>Data are expressed as median (25th, 75th quartile) or number (percentage) as indicated.</p

Characteristics of patients according to HBV genotype B or C.

<p>Data are expressed as median (25th, 75th quartile) or number (percentage) as indicated.</p>†<p>P<.001 compared with its baseline level.</p

Study flow.

Study flow.</p

Safety summary.

Safety summary.</p